Stock Information
Regeneron Pharmaceuticals Inc (REGN)
Ticker Symbol: REGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $79,953.39 mil
Piotroski score: 6
PE Ratio: 18.9796
EPS (TTM): 40.4486
Revenue (TTM): $146.55 M
Dividend Yield: 0.46651860491085%
ROE: 13.81%
Latest News
-
Nektar: Maintaining 'Strong Buy' Rating Due To REZPEG Catalyst, Another Coming
Fri, Aug 14, 2026 2:22 PM
-
If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Fri, Aug 14, 2026 12:15 PM
-
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Thu, Aug 13, 2026 11:00 AM
-
Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
Wed, Aug 12, 2026 10:41 PM
-
Infinimmune raises $75m with big pharma backing for atopic dermatitis drugs
Wed, Aug 12, 2026 11:16 AM
-
REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?
Tue, Aug 11, 2026 2:30 PM
-
American Century Focused Dynamic Growth Fund Q2 2026 Portfolio Review
Tue, Aug 11, 2026 9:30 AM
-
Regeneron Pharmaceuticals (REGN) Keeps Buybacks And Dividend In Focus As Fair Value Stays In Sight
Sat, Aug 8, 2026 11:11 PM
Key Financials
Financial data not available
